Building and sustaining collaborative platforms in genomics and biobanks for health
innovation
Genomic and biobank collaborative platforms hold significant promise for the development
of new discoveries and therapies. This paper explores the complex technical, legal
and business challenges arising from genomics and biobanks, and brings together ideas
and best practices from major national and international platforms, and from a diverse
range of experts. The global sharing of biological samples and genomic data has been
critical for accelerating our understanding of the biology and spread of COVID-19,
and for the development of vaccines and diagnostics. Although some of the policy challenges
in the field are well known, they have been reconfigured by the digitalisation of
health innovation combined with the increasing complexity and volume of data, the
push for global collaboration, and the growing awareness of ethical, legal, and social
implications.
Published on March 01, 2021
In series:OECD Science, Technology and Industry Policy Papersview more titles